Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Oppenheimer Reaffirms Their Hold Rating on Cross Country Healthcare (CCRN)

Tipranks - Tipranks - Fri Nov 21, 2025

Oppenheimer analyst Michael Wiederhorn maintained a Hold rating on Cross Country Healthcare yesterday. The company’s shares closed yesterday at $11.54.

TipRanks Black Friday Sale

Wiederhorn covers the Healthcare sector, focusing on stocks such as Guardian Pharmacy Services, Inc. Class A, Humana, and Evolent Health. According to TipRanks, Wiederhorn has an average return of 10.1% and a 58.72% success rate on recommended stocks.

The analyst consensus on Cross Country Healthcare is currently a Hold rating.

See Insiders’ Hot Stocks on TipRanks >>

Based on Cross Country Healthcare’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $250.05 million and a GAAP net loss of $4.77 million. In comparison, last year the company earned a revenue of $315.12 million and had a net profit of $2.56 million

Read More on CCRN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).